(Q38339066)

2 September 2017

title

Revealing the role of TEL/AML1 for leukemic cell survival by RNAi-mediated silencing (English)

1 reference

2 September 2017

M. Zaliova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21109770

3 September 2024

J. Madzo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21109770

3 September 2024

G. Cario

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21109770

3 September 2024

J. Trka

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21109770

3 September 2024

language of work or name

1 reference

26 November 2010

1 reference

full work available at URL

2 September 2017

https://www.nature.com/articles/leu2010277.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/LEU.2010.277

https://www.nature.com/articles/leu2010277

3 September 2024

1 reference

https://api.crossref.org/works/10.1038/LEU.2010.277

3 September 2024

1 reference

2 September 2017

volume

25

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

313-320

1 reference

ETV6: a versatile player in leukemogenesis.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

RNAi-mediated silencing of TEL/AML1 reveals a heat-shock protein- and survivin-dependent mechanism for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - a model for overcoming inhibition of proliferation by CBF oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Chromosome translocations and covert leukemic clones are generated during normal fetal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Pediatric Hematology Working Group in Czech Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

TEL-AML1 Corrupts Hematopoietic Stem Cells to Persist in the Bone Marrow and Initiate Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

The Identification of (ETV6)/RUNX1-Regulated Genes in Lymphopoiesis Using Histone Deacetylase Inhibitors in ETV6/RUNX1-Positive Lymphoid Leukemic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

7 January 2021

Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

7 January 2021

TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

7 January 2021

Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.277

7 January 2021

Biophotonics International

19

11

36

MD Abramoff

2004

1 reference

https://api.crossref.org/works/10.1038/LEU.2010.277

Journal of Clinical Investigation

3 September 2024

34

119

826

AM Ford

2009

1 reference

https://api.crossref.org/works/10.1038/LEU.2010.277

3 September 2024

Identifiers

DOI

10.1038/LEU.2010.277

1 reference

Dimensions Publication ID

2 September 2017

1034147939

0 references

1 reference